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Items for this week’s EPI Update include: 
  
 H1N1 quick points for health care providers 
 H1N1 surveillance information 
 Weather’s effect on illness 
 Meeting announcements and training opportunities 
  
H1N1 quick points for health care providers 
 Those with diabetes are at increased risk for severe disease and 
complications due to H1N1 influenza. One in four diabetic patients 
hospitalized with H1N1 required intensive care. Diabetics should receive 
vaccine when it is available, and those with confirmed or probable 
influenza should be treated promptly with oseltamivir or zanamivir.  See 
www.cdc.gov/h1n1flu/diabetes.   
 Pneumococcal vaccine is strongly recommended for those 65 years and 
over, and for those with diabetes or other long-term health problems ages 
2 through 64, to prevent secondary pneumococcal infection following 
H1N1 influenza. See 
www.cdc.gov/h1n1flu/vaccination/provider/provider_pneumococcal.htm
. 
 Obesity, especially morbid obesity, has been seen in those with serious  
H1N1 influenza infections. Patients with obesity or morbid obesity should 
be carefully evaluated for the presence of underlying medical conditions 
that are known to increase the risk for influenza complications, and 
receive empiric treatment when these conditions are present, or if signs of 
lower respiratory tract infection are present. The ACIP has not 
recommended that those who are obese, but do not have underlying 
medical conditions, be added to the target groups for vaccination.  See 
www.cdc.gov/h1n1flu/recommendations.htm  
 In the U.S., only a few cases of seasonal influenza have been identified, 
primarily influenza B. There has been one pediatric death associated with 
influenza B. No seasonal flu has been identified in Iowa. See 
www.cdc.gov/flu/weekly/. 
 Current guidelines recommend prophylaxis after exposure to H1N1 
influenza for those at higher risk of complications who have had close 
contact with confirmed or probable influenza and for health care workers 
who were not wearing appropriate PPE. See 
www.cdc.gov/h1n1flu/highrisk.htm and 
www.cdc.gov/h1n1flu/masks.htm.  
 As more vaccine becomes available, some local health departments are 
beginning to vaccinate persons in the broader ACIP target group; for 
example those up to age 64 who have chronic medical conditions. See 
www.cdc.gov/h1n1flu/vaccination/acip.htm and 
 www.cdc.gov/media/pressrel/2009/r090729b.htm.   
   
H1N1 surveillance information 
Of the 276 recent outpatient visits for influenza-like illness, 12 percent of patients 
were prescribed antiviral medication, and 11 percent of patients were prescribed 
antibiotics. Most presented with cough and a fever. 
  
Influenza activity has been declining; the highest levels of activity in schools and 
outpatient settings were reported approximately two weeks ago. However, H1N1 
activity, including hospitalizations and deaths, remains far above baseline levels. 
  
For more surveillance information, see www.idph.state.ia.us/adper/iisn.asp      
  
Weather’s effect on illness 
As we start going into the winter, not only do temperatures decrease but so does 
humidity. The loss of moisture in the air causes the mucosal membrane barrier to 
become less effective. This may be one of the reasons that respiratory viruses 
and other diseases such as meningococcal meningitis cause more illness at this 
time of year. Studies have also shown that once someone has influenza or 
another severe respiratory virus, secondary infections, both bacterial and viral 
are more common.   
  
Ensure that all patients are up to date on not only the seasonal flu vaccine (and 
the H1N1 vaccine if recommended), but pneumococcal, meningococcal, Hib, and 
any other bacterial vaccines as recommended.  Meningococcal vaccine is 
especially important for certain populations such as students living in dormitories 
and laboratorians who work with this organism. 
  
Also note: If N. meningitidis is isolated from blood or CSF, the lab must send the 
isolate to the University Hygienic Laboratory for serogrouping.  
  
Meeting announcements and training opportunities 
None 
  
Have a healthy and happy week! 
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